Patents Assigned to TEI Biosciences, Inc.
-
Patent number: 11633520Abstract: A tissue graft for soft tissue repair or reconstruction comprising a sheet of a biopolymer-based matrix having a plurality of small perforations and a plurality of large perforations. The small perforations are sized to facilitate clotting and granulation tissue development within the perforations which, in turn, facilitates revascularization and cell repopulation in the patient. The large perforations are sized to reduce the occurrence of clotting and granulation tissue development within the perforations so that extravascular tissue fluids accumulating at the implant site can drain through the tissue graft. The large perforations enhance mammal tissue anchoring by permitting mammal tissue to compress into the perforations increasing mammal tissue contact area.Type: GrantFiled: March 6, 2018Date of Patent: April 25, 2023Assignee: TEI BIOSCIENCES, INC.Inventors: Kevin Cornwell, Kenneth James
-
Patent number: 9011895Abstract: A method of forming and preserving a bioremodelable, biopolymer scaffold material by subjecting animal tissue to chemical and mechanical processing. In addition to skin tissue, another source of EBM is a blood vessel. EBM may be used for hernia repair, colon, rectal, vaginal and or urethral prolapse treatment; pelvic floor reconstruction; muscle flap reinforcement; lung tissue support; rotator cuff repair or replacement; periosteum replacement; dura repair; pericardial membrane repair; soft tissue augmentation; intervertebral disk repair; and periodontal repair. EBM may also be used as a urethral sling, laminectomy barrier or spinal fusion device.Type: GrantFiled: November 18, 2008Date of Patent: April 21, 2015Assignee: TEI Biosciences, Inc.Inventors: Jianwu Dai, Eugene Bell, Vladimir Russakovsky
-
Patent number: 7354702Abstract: A method of forming and preserving a bioremodelable, biopolymer scaffold material by subjecting animal tissue, particularly fetal or neo-natal tissue, to chemical and mechanical processing. The process includes, but is not limited to, harvesting the tissue, optionally extracting growth and differentiation factors from the tissue, inactivating infective agents of the tissue, mechanically expressing undesirable components from the tissue, delipidizing the tissue, washing the tissue, optionally drying the tissue, optionally cross-linking the tissue not necessarily in the order described. The resulting product, EBM, is characterized by its microbial, fungal, viral and prion inactivated state. EBM is strong, bioremodelable, drapable and does not undergo calcification. EBM supplants previous inventions because of its unique method of preparation and broad applicability in tissue reengineering.Type: GrantFiled: February 2, 2004Date of Patent: April 8, 2008Assignee: TEI Biosciences, Inc.Inventors: Jianwu Dai, Eugene Bell, Vladimir Russakovsky
-
Patent number: 6875397Abstract: An apparatus for forming a fiber from a biocompatible biopolymer includes a fiber-formation tube that defines a bore extending generally vertically from an upper end to a lower end. Coagulation fluid enters the tube through a fluid inlet coupled to its upper end and establishes a laminar flow of coagulation fluid within the tube. A spinneret introduces a stream of liquid biopolymer into the laminar flow of coagulation fluid so that the stream is surrounded and swept downstream by the coagulation fluid as it coagulates into a biopolymer fiber. The laminar flow of coagulation fluid surrounding the biopolymer stream maintains the shape of the stream so that the resulting fiber is homogeneous in both geometry and structure. The laminar flow of coagulation fluid also prevents the resulting fiber from contacting the inner wall of the fiber-formation tube.Type: GrantFiled: October 19, 2001Date of Patent: April 5, 2005Assignee: TEI Biosciences, Inc.Inventor: Timothy W. Fofonoff
-
Patent number: 6705850Abstract: An apparatus for forming a fiber from a biocompatible biopolymer includes a fiber-formation tube that defines a bore extending generally vertically from an upper end to a lower end. Coagulation fluid enters the tube through a fluid inlet coupled to its upper end and establishes a laminar flow of coagulation fluid within the tube. A spinneret introduces a stream of liquid biopolymer into the laminar flow of coagulation fluid so that the stream is surrounded and swept downstream by the coagulation fluid as it coagulates into a biopolymer fiber. The laminar flow of coagulation fluid surrounding the biopolymer stream maintains the shape of the stream so that the resulting fiber is homogeneous in both geometry and structure. The laminar flow of coagulation fluid also prevents the resulting fiber from contacting the inner wall of the fiber-formation tube.Type: GrantFiled: March 6, 2000Date of Patent: March 16, 2004Assignee: TEI Biosciences, Inc.Inventor: Timothy W. Fofonoff
-
Patent number: 6696074Abstract: A method of forming and preserving a bioremodelable, biopolymer scaffold material is carried out by subjecting animal tissue, particularly fetal or neo-natal tissue, to chemical and mechanical processing. The process may include, but is not limited to, harvesting the tissue, optionally extracting growth and differentiation factors from the tissue, inactivating infective agents of the tissue such as by treating with KOH or NaOH, mechanically expressing undesirable components from the tissue, delipidizing the tissue with organic solvents, mechanically expressing components released by the solvet, washing the tissue, optionally drying the tissue, and optionally cross-linking the tissue, not necessarily in the order described. The resulting product, named EB Matrix (EBM), is characterized by its microbial, fungal, viral and prion inactivated state. EBM is strong, bioremodelable, drapable and does not undergo calcification.Type: GrantFiled: May 31, 2001Date of Patent: February 24, 2004Assignee: TEI Biosciences, Inc.Inventors: Jianwu Dai, Eugene Bell, Vladimir Russakovsky
-
Patent number: 6695879Abstract: Cardiovascular components such as biocompatible heart valves and annular sewing rings are disclosed, as well as, methods for making the same. The heart valves include biodegradable polymer fiber scaffolds and collagen. Also disclosed are donor aortic heart valves processed without the use of crosslinking chemicals.Type: GrantFiled: December 19, 2001Date of Patent: February 24, 2004Assignee: TEI Biosciences, Inc.Inventor: Eugene Bell
-
Publication number: 20030185805Abstract: The applications of this invention, the use of stem cells derived from the dermis, include but are not limited to cell differentiation, histiogenesis, organogenesis, cell therapy, tissue engineering, and tissue and organ regeneration.Type: ApplicationFiled: May 5, 2003Publication date: October 2, 2003Applicant: Tei Biosciences, Inc., a Massachusetts corporationInventors: Jianwu Dai, Eugene Bell
-
Publication number: 20030165484Abstract: Methods and compositions for repairing tissue. Certain embodiments of the invention involve transdifferentiation of cells in a manner not heretofore provided for. One embodiment of the invention features methods for producing stem cells. These methods can involve exposing cells (e.g., human fibroblasts) to a processed or activated egg extract (e.g., activated egg extract); and culturing the cells for a period of time to become stem cells. A cell culture can be performed in two or three dimensions, so that organ tissue or whole organs may be produced, e.g., for transplantation. Another embodiment of the invention features methods for promoting wound healing by using signaling complexes.Type: ApplicationFiled: March 27, 2003Publication date: September 4, 2003Applicant: TEI Biosciences, Inc., a Massachusetts corporationInventors: Dai Jianwu, Bell Eugene
-
Publication number: 20030098527Abstract: An apparatus for forming a fiber from a biocompatible biopolymer includes a fiber-formation tube that defines a bore extending generally vertically from an upper end to a lower end. Coagulation fluid enters the tube through a fluid inlet coupled to its upper end and establishes a laminar flow of coagulation fluid within the tube. A spinneret introduces a stream of liquid biopolymer into the laminar flow of coagulation fluid so that the stream is surrounded and swept downstream by the coagulation fluid as it coagulates into a biopolymer fiber. The laminar flow of coagulation fluid surrounding the biopolymer stream maintains the shape of the stream so that the resulting fiber is homogeneous in both geometry and structure. The laminar flow of coagulation fluid also prevents the resulting fiber from contacting the inner wall of the fiber-formation tube.Type: ApplicationFiled: October 19, 2001Publication date: May 29, 2003Applicant: TEI Biosciences, Inc.Inventor: Timothy W. Fofonoff
-
Patent number: 6398819Abstract: Using animal tissues as starting materials, a method is described for producing extracellular matrix particulates. The invention includes an embodiment wherein the matrix particulates are applied to collagen scaffolds, which can be seeded with living cells or the particulates may alone be seeded with living cells. Further, the invention encompasses bonding the particulates to collagen foams, or collagen threads made into fabrics or to foams combined with threads. The particulates, with or without scaffolding, can be used as tissues for grafting or as model systems for research and testing. The invention also encompasses the spinning of threads on which the matrix particulates are components and the freeze drying of foams to whose surfaces the matrix particulates are attached.Type: GrantFiled: February 23, 2000Date of Patent: June 4, 2002Assignee: TEI Biosciences, Inc.Inventor: Eugene Bell
-
Patent number: 6281007Abstract: Apparatus and methods are disclosed for maturing an elongate replacement tissue construct in vitro prior to use of the replacement construct in vivo as, for example, a ligament. The tissue is seeded with specific cells, exposed to a maturation fluid, and subjected to selected forces, which can include longitudinal stress, (i.e. stressing the tissue along its elongate axis). The tissue is disposed in a maturation chamber that confines maturation fluid for introduction to the tissue. A first mounting element couples to a first end of the elongate biopolymer tissue and a second mounting element couples to a second end of the tissue such that the tissue extends along a longitudinal axis, and a force is applied to at least one of the mounting elements for longitudinally stressing the tissue. The foregoing apparatus and methods are intended to provide a replacement tissue that is more readily integrable in vivo, i.e.Type: GrantFiled: September 15, 1999Date of Patent: August 28, 2001Assignee: TEI Biosciences, Inc.Inventors: Timothy W. Fofonoff, Eugene Bell